MICHAEL P HANCOCK

Allopathic & Osteopathic Physicians|Internal Medicine BOONEVILLE, MS NPI 1104236504

General Payments — all program years on this page

$3,475.27

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 232
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $454.57 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $454.5720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $265.9420
2019 $523.9739
2020 $600.1438
2021 $800.7858
2022 $557.9439
2023 $271.9318
2024 $454.5720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097476246 Novo Nordisk Inc $15.56 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097504091 Novo Nordisk Inc $16.12 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103873037 ABBVIE INC. $19.13 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103873039 ABBVIE INC. $22.36 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104617248 AstraZeneca Pharmaceuticals LP $13.13 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105887281 AstraZeneca Pharmaceuticals LP $14.04 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105896586 AstraZeneca Pharmaceuticals LP $13.57 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116524826 GlaxoSmithKline, LLC. $14.99 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117270645 Amgen Inc. $14.31 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904657 Otsuka America Pharmaceutical, Inc. $14.88 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904659 Otsuka America Pharmaceutical, Inc. $19.02 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128592851 CVRx, Inc. $131.82 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131160971 PFIZER INC. $20.23 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131911124 PFIZER INC. $14.86 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132038304 PFIZER INC. $15.15 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135190569 Lilly USA, LLC $19.25 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148861483 Sumitomo Pharma America, Inc. $27.18 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151069697 Phathom Pharmaceuticals, Inc. $15.58 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153503372 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.59 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153540906 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.80 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.